Vaccines directed to cancer-associated carbohydrate antigens
First Claim
Patent Images
1. A vaccine for preventing or retarding growth and replication of cancer cells that express a carbohydrate antigen, said vaccine comprising:
- (a) a pharmaceutically effective amount of said carbohydrate antigen, or a mimetic of said carbohydrate antigen, wherein said carbohydrate antigen comprises Tn or sialyl Tn; and
(b) a pharmaceutically acceptable carrier.
0 Assignments
0 Petitions
Accused Products
Abstract
A vaccine and method to prevent or to retard the growth and replication of cancer cells that express a carbohydrate wherein the vaccine comprises: (a) a pharmaceutically effective amount of a carbohydrate antigen found on said cancer cells, or a mimetic thereof; and (b) a pharmaceutically acceptable carrier. The carbohydrate antigen can be Tn or sialyl-Tn.
-
Citations
2 Claims
-
1. A vaccine for preventing or retarding growth and replication of cancer cells that express a carbohydrate antigen, said vaccine comprising:
-
(a) a pharmaceutically effective amount of said carbohydrate antigen, or a mimetic of said carbohydrate antigen, wherein said carbohydrate antigen comprises Tn or sialyl Tn; and
(b) a pharmaceutically acceptable carrier. - View Dependent Claims (2)
-
Specification